(Patrick Fallon/Bloomberg The drug has surged in popularity due to its weight loss effects since it was approved by the Food and Drug Administration in 2023, but access to it hasn't always been easy due to insurance and coverage issues
Patients should not discontinue Mounjaro without consulting their prescribing clinician
01 LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Coskun T, Urva S, Roell WC, et al
Dietary Supplementation With Docosahexaenoic Acid (DHA) Improves Seminal Antioxidant Status and Decreases Sperm DNA Fragmentation
However, they act as passive AT, mainly in that they sequester transition metal ions, preventing RS formation